Michael Moore's colleague Mike Lucas weighs on the Low Dose Naltrexone issue -
Why won’t the drug companies shell out cash for a promising drug that requires FDA approval?
Thursday, 22 October 2009
Subscribe to:
Post Comments (Atom)
skip to main |
skip to sidebar
Low Dose Naltrexone is simply a much smaller dosage (Typically 1/50) of a 30 year old proven drug called Naltrexone. LDN has increasingly been shown to put a wide variety of auto-immune and other conditions (e.g. Crohn's Disease, Multiple Sclerosis (MS) into remission with virtually no side effects.
Follow us on twitter
Posts
Links
- Low Dose Naltrexone and IBD Yahoo! Group
- Low Dose Naltreone Yahoo! Group
- UK Petition for NHS Funding for an LDN Trial
- LDN on the NHS Blog
- The Essential Health Clinic Glasgow
- Google LDN by Joseph Wouk
- National Association for Colitis and Crohn's Disease (UK)
- LDN Research Trust
- lowdosenaltrexone.org
- LDNers
- Bob Thomson's LDN Experience
- LDN Now (UK)
Ads on this Site
Please note, any income form Google AdSense ads on this site is donated to The Mulitiple Sclerosis Resource Centre - http://msrc.co.uk
About Me
Followers
What is Low Dose Naltrexone (LDN)?
Low Dose Naltrexone is simply a much smaller dosage (Typically 1/50) of a 30 year old proven drug called Naltrexone. LDN has increasingly been shown to put a wide variety of auto-immune and other conditions into remission with virtually no side effects.
I have to assume that the failure of LDN to become mainstream in 30 years is due to institutional paranoia and toadying to the demands of the pharmaceutical industry by the doctors themselves who are free to prescribe LDN as a safe drug as long as they avoid wild claims of it’s effects. LDN is the biggest discovery in therapy since penicillin when you consider how many deadly diseases it can treat, and treat them safely without killer side effects. Een if it is cheap and will affect pharmaceutical industry share values, it must be made available to all, after all, we value life over wealth, don't we?
ReplyDelete